Phreesia Revenue 2019-2024 | PHR
Phreesia revenue from 2019 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| Phreesia Annual Revenue (Millions of US $) |
|
|---|---|
| 2024 | $356 |
| 2023 | $281 |
| 2022 | $213 |
| 2021 | $149 |
| 2020 | $125 |
| 2019 | $100 |
| 2018 | $80 |
| Phreesia Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2024-01-31 | $95 |
| 2023-10-31 | $92 |
| 2023-07-31 | $86 |
| 2023-04-30 | $84 |
| 2023-01-31 | $77 |
| 2022-10-31 | $73 |
| 2022-07-31 | $68 |
| 2022-04-30 | $63 |
| 2022-01-31 | $58 |
| 2021-10-31 | $56 |
| 2021-07-31 | $51 |
| 2021-04-30 | $48 |
| 2021-01-31 | $42 |
| 2020-10-31 | $38 |
| 2020-07-31 | $35 |
| 2020-04-30 | $33 |
| 2020-01-31 | $33 |
| 2019-10-31 | $33 |
| 2019-07-31 | $31 |
| 2019-04-30 | $28 |
| 2019-01-31 | |
| 2018-10-31 | $25 |
| 2018-07-31 | $25 |
| 2018-01-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.205B | $0.356B |
| Phreesia Inc. provides a patient intake management platform. The company's SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care. Phreesia Inc. is based in New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $38.069B | 20.90 |
| Inspire Medical Systems (INSP) | United States | $4.986B | 0.00 |
| Axonics (AXNX) | United States | $3.440B | 0.00 |
| 10x Genomics (TXG) | United States | $3.097B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.080B | 0.00 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.900B | 0.00 |
| Enovis (ENOV) | United States | $2.801B | 20.76 |
| Azenta (AZTA) | United States | $2.782B | 156.36 |
| Hims & Hers Health (HIMS) | United States | $2.640B | 0.00 |
| Privia Health (PRVA) | United States | $2.144B | 119.80 |
| Schrodinger (SDGR) | United States | $1.652B | 0.00 |
| Omnicell (OMCL) | United States | $1.383B | 47.81 |
| Standard BioTools (LAB) | United States | $0.696B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.651B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.627B | 0.00 |
| Talkspace (TALK) | United States | $0.477B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.406B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.378B | 0.00 |
| Pulmonx (LUNG) | United States | $0.326B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.306B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.215B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.212B | 0.00 |
| Outset Medical (OM) | United States | $0.159B | 0.00 |
| American Well (AMWL) | United States | $0.139B | 0.00 |
| TruBridge (TBRG) | United States | $0.129B | 7.07 |
| MSP Recovery (LIFW) | United States | $0.121B | 0.00 |
| Augmedix (AUGX) | United States | $0.109B | 0.00 |
| 111 (YI) | China | $0.095B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.078B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.071B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.061B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.055B | 0.00 |
| Zepp Health (ZEPP) | China | $0.052B | 0.00 |
| HeartBeam (BEAT) | United States | $0.052B | 0.00 |
| Movano (MOVE) | United States | $0.043B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.034B | 0.00 |
| Akili (AKLI) | United States | $0.034B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.021B | 0.00 |
| Cue Health (HLTH) | United States | $0.021B | 0.00 |
| CareCloud (CCLD) | United States | $0.020B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| Biotricity (BTCY) | United States | $0.012B | 0.00 |
| Syra Health (SYRA) | United States | $0.009B | 0.00 |
| Transgenomic (PRPO) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.005B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.001B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |